Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma

References

• Feig C, Gopinathan A, Neesse A, et al. The pancreas cancer microenvironment. Clin Cancer Res. 2012;18:4266–4276.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumour microenvironment. Cancer Cell. 2012;21:309–322.
   PubMed Web of Science ®Google Scholar
• Yauch RL, Gould SE, Scales SJ, et al. A paracrine requirement for hedgehog signalling in cancer. Nature. 2008;455:406–410.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang B, Shen S, et al. Tumour microenvironment modulation by cyclopamine improved photothermal therapy of biomimetic gold nanorods for pancreatic ductal adenocarcinomas. ACS Appl Mater Interfaces. 2017;9:31497–31508.
   PubMed Web of Science ®Google Scholar
• Tremblay MR, Nevalainen M, Nair SJ, et al. Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists. J Med Chem. 2008;51:6646–6649.
   PubMed Web of Science ®Google Scholar
• Park K. Facing the truth about nanotechnology in drug delivery. Acs Nano. 2013;7:7442–7447.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. Acs Nano. 2009;3:16–20.
   PubMed Web of Science ®Google Scholar
• Wu Z, de Avila BEF, Martin A, et al. RBC micromotors carrying multiple cargos towards potential theranostic applications. Nanoscale. 2015;7:13680–13686.
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Fang RH, Zhang LF. Erythrocyte-inspired delivery systems. Adv Healthcare Mat. 2012;1:537–547.
   PubMed Web of Science ®Google Scholar
• Luk BT, Fang RH, Hu CM, et al. Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics. 2016;6:1004–1011.
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA. 2011;108:10980–10985.
   PubMed Web of Science ®Google Scholar
• Copp JA, Fang RH, Luk BT, et al. Clearance of pathological antibodies using biomimetic nanoparticles. Proc Natl Acad Sci USA. 2014;111:13481–13486. [pii]
   PubMed Web of Science ®Google Scholar
• Yang RN, Mondal G, Wen D, et al. Combination therapy of paclitaxel and cyclopamine polymer-drug conjugates to treat advanced prostate cancer. Nanomed-Nanotechnol. 2017;13:391–401.
   PubMed Web of Science ®Google Scholar
• Zhang B, Jiang T, Shen S, et al. Cyclopamine disrupts tumour extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer. Biomaterials. 2016;103:12–21.
   PubMed Web of Science ®Google Scholar
• Bailey JM, Swanson BJ, Hamada T, et al. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res. 2008;14:5995–6004.
   PubMed Web of Science ®Google Scholar
• Provenzano PP, Cuevas C, Chang AE, et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21:418–429.
   PubMed Web of Science ®Google Scholar
• Zhou H, Fan Z, Deng J, et al. Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumour penetration and highly efficient antitumour efficacy. Nano Lett. 2016;16:3268–3277.
   PubMed Web of Science ®Google Scholar
• Kirtane AR, Sadhukha T, Kim H, et al. Fibrinolytic enzyme cotherapy improves tumour perfusion and therapeutic efficacy of anticancer nanomedicine. Cancer Res. 2017;77:1465–1475.
   PubMed Web of Science ®Google Scholar
• Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457–1461.
   PubMed Web of Science ®Google Scholar
• Chauhan VP, Jain RK. Strategies for advancing cancer nanomedicine. Nat Mater. 2013;12:958–962.
   PubMed Web of Science ®Google Scholar
• Yang S, Gao H. Nanoparticles for modulating tumour microenvironment to improve drug delivery and tumour therapy. Pharmacol Res. 2017;6618:30163–30169.
   Google Scholar
• Fischlechner M, Zaulig M, Meyer S, et al. Lipid layers on polyelectrolyte multilayer supports. Soft Matter. 2008;4:2245–2258.
   Web of Science ®Google Scholar
• Luk BT, Hu CMJ, Fang RNH, et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale. 2014;6:2730–2737.
   PubMed Web of Science ®Google Scholar